Sr. Medical Science Liaison I, Mid-Atlantic - Replimune, Inc.

Replimune’s mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response, boldly transforming cancer care because patient’s lives depend on it. We imagine a world where cancer is a curable disease. 

At Replimune, we live by our values: 

United: We Collaborate for a Common Goal. 

Audacious: We Are Bold and Innovative. 

Dedicated: We Give Our Full Commitment. 

Candid: We Are Honest With Each Other. 

People are at the center of everything we do, and when it comes to our employees, we make it personal.  With a deep sense of purpose, an innovative and collaborative culture, a competitive and forward-looking total rewards program, everyone at Replimune has a unique opportunity to contribute to the meaningful work we do which could impact the lives of patients, caregivers and themselves.  

Join us, as we reshape the future. 

This function will serve as a field based medical expert and will be responsible for building/strengthening collaborative relationships in support of Replimune clinical development initiatives.  This will be fulfilled mainly through the development of excellent working relationships with key opinion leaders, clinical sites, and internal stakeholders. Additional responsibilities include collection and internal dissemination of competitive intelligence, supporting portfolio expansion, and driving key pre-launch, launch, and post-marketing initiatives. 

Candidates must live in the Mid Atlantic geography to be considered for this role.

Territory includes:  Delaware, Maryland , Virginia, Washington DC area, North Carolina, South Carolina, WV, Philadelphia, Charlotte

• Identify key national and regional oncology thought leaders and priority customers, build and maintain advocacy with these individuals, and function as their primary scientific contact with Replimune.
• Participate in the collection and exchange of scientific/technical information important to Replimune development efforts (serve as a field-based extension of the in-house clinical team).
• Assist in the management of relationships between key opinion leaders and corporate product teams.
• Accumulate key competitive information to aid the clinical and marketing teams in product/brand development.
• Identify, initiate, coordinate, evaluate and monitor investigator-sponsored studies intended to support the clinical and scientific strategy of Replimune products.
• Help develop and manage to timelines publication plans of investigator-sponsored studies.
• Assist in the identification, evaluation and engagement of potential investigators for Replimune corporate trials.
• Assist the clinical trials team, as needed, in the ongoing support and communication with investigators on Replimune corporate trials.
• Education of priority customers on research and development projects.
• Develop key advocates as speakers to support Replimune products and strategies.
• Assist in the development of, and participate in, regional advisory boards and medical education programs
• Contribute scientific and clinical expertise to the development and execution of commercial educational activities.
• Provide clinical resources for programs supporting sales/sales training and marketing efforts and professional services.
• Represent Replimune at major oncology meetings and conferences, including meetings of the NCI Cooperative research groups.
• Maintain clinical and technical expertise in the area of oncology through review of the scientific literature and attendance at key scientific meetings.

• Leads assigned projects within the MSL organization
• Spearheads strategic initiatives within the MSL organization in collaboration with Directors
• Delivers updates and presentations to Medical Affairs senior management
• Develops best practices for the MSL team
• Delivers scientific / clinical presentations at advisory boards, consultant meeting, and/or facilitation of breakout sessions
• Delivers scientific / clinical presentations to payor groups and other managed market customers
• Represents MSL team on select clinical / medical study teams

• A minimum of 1 – 3 years previous MSL experience in the therapeutic area of interest required
• Patient care clinical experience in the therapeutic area (including sub-specialty) preferred
• Leadership experience (with direct reports or as an individual contributor) is a preferable trait
• Strong project leadership and management history required.
• Ability to efficiently manage time and priorities.
• Strong leadership skills and the ability to compile and disseminate information to others in a cohesive fashion to assure a clear understanding of project status and direction.
• Solid understanding of drug development and life-cycle development of a product.
• Ability to cultivate and maintain relationships with thought leaders and to establish trust through the consistent demonstration of scientific expertise and satisfactory follow-through to requests from thought-leaders; the ability to work effectively with key decision makers, both within and outside the Company.
• Excellent communicator, skilled at diplomacy and capable of effectively combining science and relationship building.
• Ability to understand and translate external customer and/or internal client needs into effective decisions and to drive results and strive for continuous improvement with high performance in the face of adversity a must.
• Willingness to travel extensively.

Educational requirements: 

• Physician Assistant or Nurse Practitioner required.  prior nursing experience required. Doctoral level nursing degree strongly preferred.    Candidates without an advanced degree are required to have at least 7 years of industry MSL experience in the therapeutic area, and 4 – 8 years overall related experience.

Candidates must live in the Mid Atlantic geography to be considered for this role.

Territory includes:  Delaware, Maryland , Virginia, Washington DC area, North Carolina, South Carolina, WV, Philadelphia, Charlotte

About Replimune 
Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of a novel portfolio of oncolytic immunotherapies. Replimune’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response. The RPx product candidates are expected to be synergistic with most established and experimental cancer treatment modalities, leading to the versatility to be developed alone or combined with a variety of other treatment options. For more information, please visit www.replimune.com.

We are an Equal Opportunity Employer.